FibroGen fibrogen.com


Public list: BIO 2016 (619) Pharma Startups (4500)

FibroGen is a biotechnology company focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. FibroGen's FG-3019 fully human monoclonal antibody is in clinical development for treatment of idiopathic pulmonary fibrosis and other proliferative diseases, including pancreatic cancer and liver fibrosis. Roxadustat (FG-4592), FibroGen's small molecule inhibitor of hypoxia-inducible factor (HIF) ...Show all

FibroGen is a biotechnology company focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. FibroGen's FG-3019 fully human monoclonal antibod...Show all

Company (IPO / Went public)

Phone: 415-978-1200

Fax:

409 Illinois Street

San Francisco, 94158
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
FibroGen $308.3M Nov 14, 2014
Amplimmune Immunology $20M Oct 7, 2013
BioMimetic Therapeutics $92M Mar 2, 2013
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related FibroGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 25 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid Jan 23, 2014 May 09, 2017 Patent
Therapeutic method for pancreatic cancer Jan 09, 2015 Apr 25, 2017 Patent
Crystalline forms of a prolyl hydroxylase inhibitor Jul 21, 2015 Apr 11, 2017 Patent
Treatment method for lung remodeling diseases Jun 17, 2015 Mar 07, 2017 Patent
Methods for treating idiopathic pulmonary fibrosis Mar 14, 2013 Nov 01, 2016 Patent
See all 59 patents